Accession Number: | 0001209191-20-011965 |
Date: | 2020-02-20 |
Issuer: | SURMODICS INC (SRDX) |
Original Submission Date: |
BEDOYA JOSE H
604 10TH STREET
BOULDER, CO 80302
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-02-20 | S | 1,821 | d | $37.51 | 21,750 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | reflects the weighted average price of 1,821 shares of common stock of surmodics,inc. sold by the reporting person in multiple transactions on february 20, 2020 with sale prices ranging from $37.51 to $37.55 per share. the reporting person undertakes to provide upon request by the u.s. securities and exchange commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
f2 | the amount beneficially owned includes 10,995 restricted stock units (rsus) that vest on service-based vesting dates and 8,430 dsus that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends. |